About GNM
Understanding how
clinical conviction is built.
GNM helps pharmaceutical and healthcare organisations understand how clinicians engage with evidence, build confidence and ultimately adopt innovation.
Our vision
We hold the standard between science and decision.
We believe better healthcare decisions emerge when scientific evidence and clinician behaviour can be understood together. GNM was built to provide the visibility pharmaceutical organisations need to bridge that gap.
Our mission
We help organisations understand how knowledge becomes practice.
For healthcare professionals
We deliver peer-reviewed content where they already work, turning fragmented science into knowledge they retain and apply at the point of care.
For the pharmaceutical industry
We help pharmaceutical teams understand which evidence resonates, where adoption is likely to emerge and what drives clinical conviction, before those changes become visible in traditional market data.
We call it Conviction Intelligence: a new category of intelligence built from real-world clinician behaviour.
Our values
The principles behind every signal we surface.
-
01
Scientific rigour
Built on peer-reviewed science and measurable behavioural signals.
-
02
Behavioural truth
We measure what HCPs do, not what they say. Action over declaration. Evidence over opinion.
-
03
Regulatory-compliant by design
Compliance is not an afterthought. It is engineered into every platform, every dataset, every interaction. From GDPR to industry codes of conduct, our infrastructure meets the standards of the most demanding pharma stakeholders.
-
04
Operational discretion
Pharma strategies are built in confidence. We work as a trusted extension of our clients' teams, never as a public broadcaster of their moves.
-
05
Long-term partnership
We build intelligence assets that become more valuable as new behavioural signals accumulate over time.
Meet the team
The people you'll work with.
A team built where strategy, science, technology and compliance converge, at every stage of your engagement.
-
Chief Executive Officer
Laurent Mastey
20+ years leading healthcare intelligence and pharmaceutical engagement.
-
Director of Operations
Elisa Le Boudec
Orchestrates operations across 50+ clinical ecosystems spanning three continents.
-
Principal Advisor, Client Strategy
Gabriela GK
18+ years across Commercial Excellence, Strategy and Launch Excellence in global pharmaceutical organisations.
-
Digital Project Leader
Julie Grimaud
Leads the digital projects that keep specialist communities engaged.
-
Chief Financial Officer
Coralie Bontent
Financial stewardship for a growing international intelligence group.
-
Chief Technical Officer
Anthony Colle
Architect of the platforms that capture and structure behavioural signal.
-
Global Chief Privacy Officer
Fabienne Bohm
Global privacy and data-protection leadership across international healthcare initiatives.
-
Publishers Relations
Sierra Gindre
Cultivates long-term partnerships with healthcare publishers, ensuring broad specialist reach across GNM ecosystems.
-
Senior Digital Designer
Sébastien Lopez
Designs the digital experiences clinicians trust across GNM ecosystems.
-
Scientific Director
Thomas Bohm
Guardian of the scientific rigour behind every signal GNM surfaces.
Where we operate
Global reach. Local healthcare understanding.
Our teams operate across major pharmaceutical markets, combining global strategic support with local healthcare intelligence and specialist community access. HCP coverage and regional intelligence sit on the Network page.
- North America New York View GNM New York office
- Europe Paris View GNM Paris office
- Asia Pacific Tokyo View GNM Tokyo office
Why clients work with us.
- Access behavioural signals unavailable through traditional sources.
- Understand scientific influence beyond conventional KOL mapping.
- Detect adoption opportunities earlier.
- Activate trusted specialist communities.
- Build intelligence that compounds over time.